- Investing Ideas
- /
- Global Small Cap High Growth Stocks
Global Small Cap High Growth Stocks
UPDATED May 06, 2024
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
2,337 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
FWRY | ج.م5.93 | -3.4% | -0.3% | ج.م20.2b | ج.م7.20 | PE32.7x | E34.8% | n/a | Diversified Financials | ||
ELABS | kr15.58 | -3.9% | 28.1% | kr1.6b | kr25.00 | PS23.9x | E124.6% | n/a | Software | ||
WAYS | kr22.60 | -2.2% | -53.2% | kr182.4m | kr39.75 | PS1.6x | E81.8% | 0% | Tech | ||
NOHAL | kr22.60 | 5.6% | -11.0% | kr883.8m | kr32.50 | PS8.7x | E56.0% | n/a | Food, Beverage & Tobacco | ||
NEWBRY | kr3.09 | -9.4% | -44.4% | kr75.0m | kr8.00 | PS3.3x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
KEBNI B | kr1.44 | -5.8% | 30.3% | kr389.4m | kr2.20 | PS4.3x | E90.4% | n/a | Tech | ||
OSE | €6.33 | 14.7% | 62.1% | €136.5m | €7.15 | PS61.3x | E92.9% | n/a | Pharmaceuticals & Biotech | ||
NVG | zł2.06 | -1.0% | 35.5% | zł72.1m | zł3.71 | PE14.3x | E30.8% | n/a | Diversified Financials | ||
MVW | kr7.90 | -6.5% | 3.4% | kr258.5m | kr13.00 | PS23.5x | E66.8% | n/a | Materials | ||
GWIND | ₺29.48 | 0.6% | 106.0% | ₺15.9b | ₺39.79 | PE25.5x | E60.9% | 1.6% | Utilities | ||
ATAKP | ₺45.58 | -2.6% | n/a | ₺6.3b | ₺67.66 | PE21.4x | E72.8% | n/a | Food, Beverage & Tobacco | ||
AGP | €8.65 | 11.8% | 147.9% | €149.8m | €12.75 | PE30.4x | E22.8% | n/a | Capital Goods | ||
GIG | kr32.90 | -2.2% | 19.6% | kr4.3b | kr49.14 | PE27.2x | E40.7% | n/a | Consumer Services | ||
ADOC | €8.37 | 0.1% | 123.2% | €119.6m | €9.70 | PS19.8x | E104.5% | n/a | Pharmaceuticals & Biotech | ||
FDE | €35.20 | 6.7% | -1.1% | €184.1m | €64.07 | PE23.4x | E37.6% | n/a | Energy | ||
RDUE | €9.65 | 1.6% | 4.9% | €60.3m | €10.50 | PE17.8x | E37.7% | n/a | Capital Goods | ||
RCEL | US$8.90 | 2.1% | -44.5% | US$229.6m | US$25.90 | PS4.6x | E62.0% | n/a | Pharmaceuticals & Biotech | ||
ZVRA | US$5.16 | 13.3% | 4.8% | US$215.7m | US$19.00 | PS7.9x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
AVLL3 | R$3.79 | 3.0% | 30.7% | R$742.3m | R$9.90 | PS1.6x | E101.9% | n/a | Consumer Durables | ||
3DA | AU$0.48 | 14.3% | 255.6% | AU$243.7m | n/a | PS309.9x | E80.5% | n/a | Capital Goods | ||
CYC | AU$1.72 | -1.7% | -20.0% | AU$162.9m | AU$4.35 | PS6x | E89.2% | 0% | Healthcare | ||
A254490 | ₩18,590.00 | -0.6% | -3.6% | ₩268.4b | n/a | PE53x | E75.7% | n/a | Tech | ||
A179900 | ₩35,000.00 | -0.3% | 54.5% | ₩553.8b | ₩60,000.00 | PS28.6x | E111.6% | 0% | Tech | ||
A080160 | ₩16,790.00 | 0.06% | 0.8% | ₩296.4b | ₩17,666.67 | PE64.9x | E67.7% | 1.5% | Consumer Services |